サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1462931

皮膚発疹治療の世界市場：治療タイプ別、皮膚発疹タイプ別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024～2032年）

Skin Rash Treatment Market, By Treatment Type, By Skin Rash Type, By Distribution Channel, By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 355 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
皮膚発疹治療の世界市場：治療タイプ別、皮膚発疹タイプ別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024～2032年）
出版日: 2024年04月14日
発行: AnalystView Market Insights
ページ情報: 英文 355 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の皮膚発疹治療の市場規模は、2023年に32億4,552万米ドルに達し、2024～2032年にかけてCAGR 6.3％で拡大すると予測されています。

皮膚発疹治療の市場力学

皮膚アレルギーおよび関連疾患の有病率の増加が市場需要を促進

皮膚アレルギーおよび関連疾患の世界の有病率は、ここ数十年で着実に増加しています。この増加は、環境汚染の深刻化、ライフスタイルや食習慣の変化、化学物質への曝露の増加など、いくつかの要因に起因しています。都市化によってこの傾向はさらに悪化しており、都市での生活は日常的に環境中に存在する多数のアレルゲンや刺激物質に個人をさらすことになります。調査によると、現代の家庭には、洗浄剤、芳香剤、香料のついたパーソナルケア用品、合成家具など、一般的に使用されている製品に含まれる、潜在的なアレルギーの誘因が数多く存在しています。同時に、さまざまな皮膚疾患に対する認識が高まり、特に医療インフラや診断能力の進歩が進む発展途上地域での診断が増加しています。人口動態の変化も有病率に影響を及ぼしており、高齢者と若年者の両方が特定のアレルギー性皮膚疾患の高い発症率を示しています。さらに、製薬産業は、健康キャンペーンを通じて様々な皮膚疾患に対する一般市民の意識を高める上で重要な役割を果たしており、一般市民の間でこれらの疾患に対する認識と理解を深めることに効果的に寄与しています。

皮膚発疹治療市場の主要洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）にCAGR 約6.3％で毎年成長すると予測されています。

治療タイプのセグメンテーションに基づくと、副腎皮質ステロイドが2023年に最大の市場シェアを示すと予測されました。

皮膚発疹タイプ別では、乾癬が2023年の主要タイプです。

地域別では、北米が2023年の売上高をリードしています。

皮膚発疹治療市場セグメンテーション分析：

皮膚発疹治療の世界市場は、治療タイプ、皮膚発疹タイプ、流通チャネル、地域に基づいてセグメント化されます。

市場は治療タイプに基づいて5つに分類されます。：副腎皮質ステロイド薬、免疫抑制剤、抗ヒスタミン薬、抗真菌薬、その他です。副腎皮質ステロイド薬セグメントは、主に様々なタイプの皮疹の治療におけるその有効性により、2023年も市場において支配的な地位を維持する見通しです。副腎皮質ステロイドは、炎症を抑え、皮膚の炎症やアレルギー反応を緩和することで機能します。副腎皮質ステロイドは、湿疹、乾癬、接触性皮膚炎など多くの炎症性・自己免疫性皮膚疾患に関連する症状を一時的に緩和するのに特に効果的です。このような皮膚疾患の世界の発生率の高まりが、コルチコステロイド薬の需要に拍車をかけています。学術医療センターであるPenn Medicineが発表した研究によると、2022年3月には、3,200万人以上のアメリカ人が湿疹に苦しみ、750万人以上のアメリカ人が乾癬に悩まされています。これらの疾患は再発を繰り返すという性質に加え、誘因を適切に特定し、再燃を予防するという課題もあるため、効果的な治療オプションの必要性が常に強調され、副腎皮質ステロイドの分野に利益をもたらしています。さらに、処方薬と並んで一般用医薬品（OTC）が普及したことで、より多くの人々がコルチコステロイド製剤を利用できるようになり、その結果、皮膚発疹治療市場における同分野の成長を後押ししています。

市場は皮疹のタイプによって5つのカテゴリーに分けられます。：接触性皮膚炎、アトピー性皮膚炎（湿疹）、乾癬、脂漏性皮膚炎、その他です。乾癬分野は2023年に市場シェアをリードすると予測されています。乾癬は、かゆみ、かさつき、炎症を特徴とする異常な皮膚の斑点として現れます。再発は誘因によって頻繁に起こり、不快感を引き起こし、日常生活に支障をきたします。乾癬は時間の経過とともに、他の重篤な健康合併症の発症リスクを高める可能性があります。乾癬に罹患している患者は世界中に多数存在するため、効果的な治療および管理オプションに対する需要は依然として根強いです。この持続的な需要が乾癬分野への注目と新製品開発を促進しています。近年、乾癬に特化したいくつかの生物学的製剤やその他の先進治療が導入され、患者がより良好な疾患コントロールを達成できるよう支援しています。さらに、乾癬と利用可能な治療オプションに関する認知度の向上は、より多くの患者が医療介入を求めることを促し、それによって皮膚発疹治療市場における乾癬セグメントの成長を促進しています。

皮膚発疹治療市場の地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分割されます。

皮膚発疹治療市場の競合情勢：

皮膚発疹治療の競争領域では、企業は市場での存在感を高め、包括的なソリューションを提供するために戦略的パートナーシップを頻繁に活用しています。製薬企業と皮膚科医や医療機関との提携は、革新的な治療法や臨床試験の開発を促進します。スキンケアブランドや小売チェーンとの提携により、企業は流通網を広げ、より幅広い消費者層にリーチすることができます。さらに、研究機関やトリートメントタイプ企業との提携は、診断や個別化治療アプローチの進歩に拍車をかける可能性があります。戦略的提携による相乗効果を活用することで、皮膚発疹治療市場の企業は競争力を強化し、患者の多様なニーズに効果的に対応することができます。

目次

第1章 皮膚発疹治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 皮膚発疹治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 皮膚発疹治療の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 皮膚発疹治療市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 皮膚発疹治療の市場情勢

  • 皮膚発疹治療市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存プレイヤーの分析
    • 新興プレーヤーの分析

第7章 皮膚発疹治療市場 - 治療タイプ別

  • 概要
    • セグメントシェア分析、治療タイプ別
    • 副腎皮質ステロイド
    • 免疫抑制剤
    • 抗ヒスタミン薬
    • 抗真菌薬
    • その他

第8章 皮膚発疹治療市場 - 皮膚発疹タイプ別

  • 概要
    • セグメントシェア分析、皮膚発疹タイプ別
    • 接触性皮膚炎
    • アトピー性皮膚炎（湿疹）
    • 乾癬
    • 脂漏性皮膚炎
    • その他

第9章 皮膚発疹治療市場 - 流通チャネル別

  • 概要
    • セグメントシェア分析、流通チャネル別
    • 薬局
    • 小売店

第10章 皮膚発疹治療市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 皮膚発疹治療産業

  • 競合ダッシュボード
  • 企業プロファイル
    • AbbVie
    • Amgen
    • Bristol Myers Squibb
    • Galderma
    • Johnson &Johnson
    • LEO Pharma
    • Merck &Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Sun Pharmaceutical Industries Pvt. Ltd.
    • Teva Pharmaceutical Industries
    • Valeant Pharmaceuticals
    • Mylan NV
    • Perrigo Company plc
    • Eli Lilly and Company
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Skin Rash Treatment Market: Treatment Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Skin Rash Treatment Market, by Treatment Type 2019-2032 (USD Million)
  • TABLE Skin Rash Treatment Market: Skin Rash Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Skin Rash Type
  • TABLE Global Skin Rash Treatment Market, by Skin Rash Type 2019-2032 (USD Million)
  • TABLE Skin Rash Treatment Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Skin Rash Treatment Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Skin Rash Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Skin Rash Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Skin Rash Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Skin Rash Treatment Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE North America Skin Rash Treatment Market, by Skin Rash Type, 2019-2032 (USD Million)
  • TABLE North America Skin Rash Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Skin Rash Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Skin Rash Treatment Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Europe Skin Rash Treatment Market, by Skin Rash Type, 2019-2032 (USD Million)
  • TABLE Europe Skin Rash Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Skin Rash Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Skin Rash Treatment Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Skin Rash Treatment Market, by Skin Rash Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Skin Rash Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Skin Rash Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Skin Rash Treatment Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Latin America Skin Rash Treatment Market, by Skin Rash Type, 2019-2032 (USD Million)
  • TABLE Latin America Skin Rash Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Skin Rash Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Skin Rash Treatment Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Skin Rash Treatment Market, by Skin Rash Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Skin Rash Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • FIGURE Skin Rash Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Treatment Type segment market share analysis, 2023 & 2032
  • FIGURE Treatment Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Skin Rash Type segment market share analysis, 2023 & 2032
  • FIGURE Skin Rash Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2023 & 2032
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Skin Rash Treatment Market share and leading players, 2023
  • FIGURE Europe Skin Rash Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Skin Rash Treatment Market share and leading players, 2023
  • FIGURE Latin America Skin Rash Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Skin Rash Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Skin Rash Treatment Market share analysis by country, 2023
  • FIGURE Germany Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Skin Rash Treatment Market share analysis by country, 2023
  • FIGURE India Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Skin Rash Treatment Market share analysis by country, 2023
  • FIGURE Brazil Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Skin Rash Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Skin Rash Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2389

REPORT HIGHLIGHT

Skin Rash Treatment Market size was valued at USD 3,245.52 Million in 2023, expanding at a CAGR of 6.3% from 2024 to 2032.

The treatment of skin rashes encompasses a variety of approaches tailored to the underlying cause and severity of the condition. Typically, treatment options may involve the use of over-the-counter or prescription topical creams or ointments aimed at reducing inflammation and alleviating itching. In cases of persistent itching and discomfort, antihistamines may be prescribed, while severe instances may necessitate oral corticosteroids. It is crucial to identify and avoid triggers such as specific allergens or irritants to effectively manage chronic skin conditions. Moreover, maintaining proper skincare hygiene and utilizing gentle, non-irritating products can aid in preventing flare-ups and promoting healing.

Skin Rash Treatment Market Dynamics

Escalating prevalence of skin allergies and related conditions to propel market demand

The global prevalence of skin allergies and related conditions has exhibited a steady increase over recent decades. This rise is attributed to several factors, including escalating environmental pollution, shifts in lifestyle and dietary habits, and heightened exposure to chemicals. Urbanization has further compounded this trend, as city living exposes individuals to a multitude of allergens and irritants present in the environment on a daily basis. Research indicates that modern households now harbor numerous potential allergy triggers, found in commonly used products such as cleaning agents, air fresheners, fragranced personal care items, and synthetic furnishings. Concurrently, heightened awareness of various skin conditions has led to increased diagnoses, particularly in developing regions where advancements in medical infrastructure and diagnostic capabilities are underway. Demographic changes have also influenced prevalence rates, with both elderly and younger individuals exhibiting higher incidence rates of certain allergic skin conditions. Additionally, the pharmaceutical industry has played a significant role in raising public awareness about various skin issues through health campaigns, effectively contributing to greater recognition and understanding of these conditions among the general population.

Skin Rash Treatment Market Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2024-2032)

Based on Treatment Type segmentation, corticosteroids was predicted to show maximum market share in the year 2023

Based on Skin Rash Type segmentation, psoriasis was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Skin Rash Treatment Market Segmentation Analysis:

The Global Skin Rash Treatment Market is segmented on the basis of Treatment Type, Skin Rash Type, Distribution Channel, and Region.

The market is divided into five categories based on Treatment Type: Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Others. The corticosteroids segment is poised to maintain its dominant position in the market in 2023, primarily due to its efficacy in treating various types of skin rashes. Corticosteroids function by reducing inflammation and alleviating irritations and allergic reactions on the skin. They are particularly effective in providing temporary relief from symptoms associated with numerous inflammatory and autoimmune-based dermatological conditions such as eczema, psoriasis, and contact dermatitis. The escalating global incidence of these skin problems is fueling the demand for corticosteroid medications. According to studies released by Penn Medicine, an academic medical center, in March 2022, over 32 million Americans suffer from eczema, while more than 7.5 million Americans are afflicted with psoriasis. The recurrent nature of these conditions, coupled with the challenge of properly identifying triggers and preventing flare-ups, underscores the consistent necessity for effective treatment options, thus benefiting the corticosteroid segment. Furthermore, the proliferation of over-the-counter (OTC) corticosteroid formulations alongside prescription drugs has broadened their accessibility to a larger population, consequently bolstering the growth of this segment in the skin rash treatment market.

The market is divided into five categories based on Skin Rash Type: Contact Dermatitis, Atopic Dermatitis (Eczema), Psoriasis, Seborrheic Dermatitis and Others. The psoriasis segment is anticipated to lead the market share in 2023. Psoriasis manifests as patches of abnormal skin that are characterized by itchiness, scaliness, and inflammation. Flare-ups can occur frequently depending on triggers, causing discomfort and interfering with daily activities. Over time, psoriasis may elevate the risk of developing other serious health complications. With a substantial global patient pool affected by psoriasis, there remains a persistent demand for effective treatment and management options. This sustained demand is driving attention and new product development toward the psoriasis segment. Several biologics and other advanced therapies have been introduced in recent years, specifically targeting psoriasis and aiding patients in achieving better disease control. Moreover, increased awareness about psoriasis and available treatment options has encouraged more patients to seek medical intervention, thereby propelling the growth of the psoriasis segment in the skin rash treatment market.

Skin Rash Treatment Market Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Skin Rash Treatment Market Competitive Landscape:

In the competitive realm of skin rash treatment, companies frequently utilize strategic partnerships to bolster their market presence and provide comprehensive solutions. Collaborations between pharmaceutical firms and dermatologists or medical institutions can facilitate the development of innovative treatments and clinical trials. Partnerships with skincare brands or retail chains allow companies to broaden their distribution networks and reach a wider consumer base. Furthermore, alliances with research organizations or Treatment Type firms may spur advancements in diagnostics and personalized treatment approaches. By capitalizing on synergies through strategic partnerships, companies within the skin rash treatment market can fortify their competitive stance and effectively address the diverse needs of patients.

Recent Developments:

In May 2022, Dermavant Sciences, a biopharmaceutical company, announced the approval of VTAMA (tapinarof) cream, 1%, by the U.S. Food and Drug Administration (FDA). This cream, an aryl hydrocarbon receptor agonist, is indicated for the topical treatment of plaque psoriasis in adults. The approval marks VTAMA cream as the first and only FDA-approved steroid-free topical medication in its class, highlighting a significant advancement in the field.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SKIN RASH TREATMENT MARKET KEY PLAYERS DETAILED COMPETITIVE INSIGHT

AbbVie

Amgen

Bristol Myers Squibb

Galderma

Johnson & Johnson

LEO Pharma

Merck & Co. Inc.

Novartis AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Pvt. Ltd.

Teva Pharmaceutical Industries

Valeant Pharmaceuticals

Mylan N.V.

Perrigo Company plc

Eli Lilly and Company

Others

GLOBAL SKIN RASH TREATMENT MARKET, BY TREATMENT TYPE MARKET ANALYSIS, 2019 2032

  • Corticosteroids
  • Immunosuppressants
  • Antihistamines
  • Antifungals
  • Others

GLOBAL SKIN RASH TREATMENT MARKET, BY SKIN RASH TYPE MARKET ANALYSIS, 2019 2032

  • Contact Dermatitis
  • Atopic Dermatitis (Eczema)
  • Psoriasis
  • Seborrheic Dermatitis
  • Others

GLOBAL SKIN RASH TREATMENT MARKET, BY DISTRIBUTION CHANNEL MARKET ANALYSIS, 2019 2032

  • Pharmacies
  • Retail Stores
  • Others GLOBAL SKIN RASH TREATMENT MARKET, BY REGION MARKET ANALYSIS, 2019 2032
  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Skin Rash Treatment Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Skin Rash Treatment Market Snippet by Treatment Type
    • 2.1.2.Skin Rash Treatment Market Snippet by Skin Rash Type
    • 2.1.3.Skin Rash Treatment Market Snippet by Distribution Channel
    • 2.1.4.Skin Rash Treatment Market Snippet by Country
    • 2.1.5.Skin Rash Treatment Market Snippet by Region
  • 2.2.Competitive Insights

3.Skin Rash Treatment Key Market Trends

  • 3.1.Skin Rash Treatment Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Skin Rash Treatment Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Skin Rash Treatment Market Opportunities
  • 3.4.Skin Rash Treatment Market Future Trends

4.Skin Rash Treatment Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Skin Rash Treatment Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Skin Rash Treatment Market Landscape

  • 6.1.Skin Rash Treatment Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Skin Rash Treatment Market - By Treatment Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 7.1.2.Corticosteroids
    • 7.1.3.Immunosuppressants
    • 7.1.4.Antihistamines
    • 7.1.5.Antifungals
    • 7.1.6.Others

8.Skin Rash Treatment Market - By Skin Rash Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Skin Rash Type, 2023 & 2032 (%)
    • 8.1.2.Contact Dermatitis
    • 8.1.3.Atopic Dermatitis (Eczema)
    • 8.1.4.Psoriasis
    • 8.1.5.Seborrheic Dermatitis
    • 8.1.6.Others

9.Skin Rash Treatment Market - By Distribution Channel

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2.Pharmacies
    • 9.1.3.Retail Stores

10.Skin Rash Treatment Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Skin Rash Treatment Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Skin Rash Treatment Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Skin Rash Treatment Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Skin Rash Treatment Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Skin Rash Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Skin Rash Treatment Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.AbbVie
    • 11.2.2.Amgen
    • 11.2.3.Bristol Myers Squibb
    • 11.2.4.Galderma
    • 11.2.5.Johnson & Johnson
    • 11.2.6.LEO Pharma
    • 11.2.7.Merck & Co. Inc.
    • 11.2.8.Novartis AG
    • 11.2.9.Pfizer Inc.
    • 11.2.10.Sanofi
    • 11.2.11.Sun Pharmaceutical Industries Pvt. Ltd.
    • 11.2.12.Teva Pharmaceutical Industries
    • 11.2.13.Valeant Pharmaceuticals
    • 11.2.14.Mylan N.V.
    • 11.2.15.Perrigo Company plc
    • 11.2.16.Eli Lilly and Company
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us